Who are p53 gene with surgery's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/p53-gene-with-surgery.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

p53 gene with surgery — Competitive Intelligence Brief

p53 gene with surgery (p53 gene with surgery) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Gene therapy (p53 tumor suppressor). Area: Oncology.

marketed Gene therapy (p53 tumor suppressor) p53 (tumor protein p53) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

p53 gene with surgery (p53 gene with surgery) — Shenzhen SiBiono GeneTech Co.,Ltd. A p53 gene therapy that restores wild-type p53 tumor suppressor function in cancer cells, typically administered intratumorally in combination with surgical resection.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
p53 gene with surgery TARGET	p53 gene with surgery	Shenzhen SiBiono GeneTech Co.,Ltd	marketed	Gene therapy (p53 tumor suppressor)	p53 (tumor protein p53)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Gene therapy (p53 tumor suppressor) class)

Shenzhen SiBiono GeneTech Co.,Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). p53 gene with surgery — Competitive Intelligence Brief. https://druglandscape.com/ci/p53-gene-with-surgery. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab